Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
7-Chloro-2-tetralone serves as a key drug intermediate in the synthesis of various bioactive compounds. This compound is instrumental in the development of pharmaceuticals, particularly in medicinal chemistry endeavors. Its structural features facilitate the construction of complex molecular architectures, making it valuable for research applications in drug discovery. -
Drug Intermediate
Ethyl 1,8-dimethyl-4-oxo-4,5-dihydroimidazo[1,2-a]quinoxaline-2-carboxylate serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This reagent is integral to the development of pharmaceuticals, facilitating the formation of complex molecular structures. Its unique imidazoquinoxaline framework supports various biological activities, making it valuable in chemical research and drug discovery applications. -
Drug Intermediate
4-Phenylpyridin-2-ol functions as a versatile drug intermediate, primarily utilized in the synthesis of heterocyclic compounds. Its unique structural properties facilitate various chemical reactions, making it an essential building block in pharmaceutical research and development. This reagent is valuable for researchers focused on developing novel therapeutic agents and enhancing the chemical diversity of drug candidates. -
Drug Intermediate
2'-Hydroxypropiophenone serves as a critical intermediate in the synthesis of 1,2-benzisoxazole prodrugs, including 1,2-benzisoxazole phosphorodiamidates. This compound exhibits significant potential in cancer research, facilitating the exploration of novel therapeutic strategies. Its role in drug development makes it an important tool for studies focused on anticancer efficacy and mechanism of action. -
Drug Impurity
Nimesulide impurity 4, also known as Aminodiphenylether, is a chemical impurity associated with the analgesic and anti-inflammatory drug Nimesulide. This compound is important for assessing the quality and safety of pharmaceutical formulations in drug development and regulatory compliance. It serves as a reference standard for analytical methods aimed at identifying and quantifying impurities in Nimesulide products. -
Drug Intermediate
tert-Butyl 2-{3-[3-(3,4-dimethoxyphenyl)propanoyl]phenoxy}acetate serves as a pivotal drug intermediate in the synthesis of various bioactive compounds. Its structural features facilitate the development of pharmaceuticals with specific therapeutic activities. This reagent is utilized extensively in chemical research, particularly in the fields of medicinal chemistry and drug development. -
Drug Impurity
Apixaban impurity 20 is a chemical impurity associated with the anticoagulant drug Apixaban. Its characterization is crucial for ensuring the purity and safety of Apixaban formulations. This impurity can serve as a reference standard in analytical chemistry, facilitating research and quality control in pharmaceutical development and regulatory compliance. -
Drug Impurity
Ibrutinib Impurity 28 is an impurity associated with Ibrutinib, a selective inhibitor targeting Bruton's tyrosine kinase (BTK). This compound is essential for analytical and quality control applications in pharmaceutical research, aiding in the characterization and assessment of Ibrutinib formulations. The study of impurities such as Ibrutinib Impurity 28 is crucial for ensuring the purity and efficacy of pharmaceutical products. -
Drug Impurity
Montelukast impurity 3 is a detectable impurity associated with the asthma medication Montelukast, a leukotriene receptor antagonist. This compound is important for analytical chemistry studies, specifically in evaluating the purity and stability of Montelukast formulations. Researchers utilize this impurity to assess quality control metrics and ensure compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Amoxicillin Impurity 7 is a known impurity of the antibiotic compound Amoxicillin, primarily serving as a reference standard in analytical chemistry. This compound is crucial for the assessment of drug purity and quality control in pharmaceutical research. Its characterization aids in understanding the stability and degradation pathways of Amoxicillin, facilitating compliance with regulatory requirements in drug formulation and development. -
Drug Intermediate
6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4(1H)-one serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound is integral for the development of therapeutics focusing on various biological targets. Its unique structural features may enhance the efficacy and selectivity of resulting derivatives in drug discovery and development applications. -
Drug Intermediate
2,2-Dimethyl-1-(2-thioxothiazolidin-3-yl)propan-1-one serves as a pivotal drug intermediate in the synthesis of various bioactive compounds. Its structure facilitates the formation of thiazolidine derivatives, which are often utilized in medicinal chemistry research. This reagent is essential for studies focused on compound development and optimization in drug discovery. -
Drug Intermediate
(R)-3-Oxo-cyclopentanecarboxylic acid methyl ester is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound exhibits versatility in the formation of biologically active molecules, facilitating the development of potential drug candidates. Its structural features make it valuable for various applications in medicinal chemistry and organic synthesis. -
Drug Impurity
Aripiprazole impurity 23 is a recognized impurity associated with the antipsychotic compound Aripiprazole. This impurity is critical for quality control and analytical studies in pharmaceutical research, allowing for the assessment of drug purity and stability. Its identification and quantification are important for ensuring compliance with regulatory standards and understanding the drug’s profile in formulations. -
Drug Impurity
Lamivudine impurity 4 is a drug impurity associated with Lamivudine, an antiretroviral medication. This compound is relevant for analytical studies and quality control processes in pharmaceutical research, particularly for ensuring the purity and safety of Lamivudine formulations. Its identification and quantification can aid in understanding process-related impurities that may affect drug efficacy and patient safety. -
Drug Impurity
Bupropion impurity 13 is identified as a drug impurity associated with bupropion. It serves as a critical compound for analytical chemistry studies and quality control in pharmaceutical development. Researchers can utilize this impurity to assess the purity and stability of bupropion formulations, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Neratinib impurity 11 is a drug impurity associated with Neratinib, a potent irreversible inhibitor of the human epidermal growth factor receptor 2 (HER2). This impurity may be utilized in the characterization and quality control of Neratinib during pharmaceutical development. Its detailed analysis is essential for ensuring the integrity and safety of HER2-targeted therapies. -
Drug Impurity
Lidocaine impurity 12 is a known impurity of the local anesthetic Lidocaine, which primarily acts as a sodium channel blocker. This compound is valuable for research involving drug formulation and stability studies, as it aids in understanding the impact of impurities on pharmacological profiles. Its characterization is essential for ensuring the quality and safety of Lidocaine-containing formulations. -
Drug Intermediate
7-Chloro-6-nitroquinoline serves as a crucial intermediate for the synthesis of diverse bioactive compounds. Its unique chemical structure facilitates the production of various pharmaceuticals with potential therapeutic applications. This compound is instrumental in chemical research and development within the field of medicinal chemistry. -
Drug Intermediate
1-(5-Chloro-2-phenoxyphenyl)ethanone serves as a crucial intermediate in the synthesis of diverse bioactive compounds. This compound is utilized primarily in pharmaceutical research, contributing to the development of various therapeutic agents. Its versatile structure facilitates the creation of targeted drugs in medicinal chemistry. -
Drug Intermediate
(3R)-4-(4-Fluorobenzoyl)-3-methyl-2-piperazinone serves as a key drug intermediate in the synthesis of diverse bioactive compounds. This intermediate exhibits crucial chemical properties that facilitate the development of pharmaceuticals. Its application in medicinal chemistry underscores its importance in the preparation of targeted therapeutic agents. -
Drug Intermediate Control
N'-Hydroxy-3-methylbenzenecarboximidamide acts as a drug intermediate in pharmaceutical synthesis. This compound is essential for the development of various active pharmaceutical ingredients (APIs) and has applications in medicinal chemistry for the preparation of biologically active molecules. Its structural features enable effective functionalization and incorporation into diverse chemical pathways, facilitating innovative drug discovery and development processes. -
Drug Impurity
Pitavastatin impurity 12 is a known impurity of Pitavastatin, a statin used for cholesterol management. This compound serves as a critical analytical standard for the assessment of purity in drug formulation and research. Its identification and quantification are essential for ensuring the quality and safety of statin-based therapies in pharmaceutical development. -
Drug Impurity
Valproic acid impurity 1 is a known impurity associated with Valproic acid, primarily functioning as a drug impurity. It is relevant in the study of pharmaceutical formulations and drug purity analysis, serving as a standard reference for quality control and regulatory compliance in the development of Valproic acid-containing medications. This compound is essential for understanding the implications of drug impurities on therapeutic efficacy and safety. -
Drug Impurity
Ticagrelor impurity 27 is a chemical impurity derived from the antiplatelet agent Ticagrelor. This reagent is essential for impurity profiling and quality assurance in the synthesis of Ticagrelor. Its characterization is crucial for regulatory compliance and ensuring the safety and efficacy of pharmaceutical formulations. Researchers can utilize this impurity to study the metabolic pathways and potential effects related to Ticagrelor administration. -
Drug Impurity
Rotigotine impurity 2 is a chemical impurity associated with Rotigotine, a dopaminergic anti-Parkinson agent. As a drug impurity, it is essential for quality control and analytical research in pharmaceutical development. Understanding and characterizing this impurity can aid in assessing the safety, efficacy, and stability of Rotigotine formulations in drug development processes. -
Drug Impurity
Vonoprazan impurity 46 is a known impurity of the proton pump inhibitor Vonoprazan, which acts by inhibiting the H+/K+ ATPase in gastric parietal cells. This impurity is vital for quality control during the synthesis of Vonoprazan, aiding in the identification and characterization of the compound. Its analysis is essential for ensuring the purity and efficacy of formulations containing Vonoprazan in pharmaceutical research. -
Drug Impurity
Rosuvastatin impurity 47 is a specific impurity identified in the synthesis of Rosuvastatin. This compound serves as a crucial reference standard for the quality control and analysis of Rosuvastatin formulations. Its characterization is vital for ensuring compliance with pharmaceutical regulations and for understanding the compound's overall purity and stability in drug development applications. -
Drug Impurity
Indobufen impurity 2 is a known impurity of the pharmaceutical compound Indobufen. It is utilized primarily in analytical chemistry and pharmaceutical development to assess the purity of Indobufen formulations. This impurity may play a role in understanding the compound's stability and potential side effects in drug formulation and safety assessments. -
Drug Intermediate
6-(2-Hydroxyethoxy)-1-hexanol serves as a versatile drug intermediate in the synthesis of a range of active pharmaceutical ingredients. Its unique chemical structure facilitates the formation of various derivatives, making it valuable in medicinal chemistry research and development. This compound is essential for advancing the synthesis of potential therapeutic agents. -
Drug Impurity
Palbociclib impurity 2 is a known chemical impurity associated with Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. This compound is critical in quality control and analytical studies related to Palbociclib synthesis, providing insight into the stability and purity of the final product. Research applications include assessing drug safety and efficacy, as well as developing purification methodologies in pharmaceutical development. -
Drug Intermediate
Methyl 2-nitro-p-tolyl ether serves as a crucial drug intermediate, facilitating the synthesis of a variety of biologically active compounds. Its application in chemical research plays a significant role in the development of pharmaceuticals, allowing for the creation of novel therapeutic agents. This compound's unique structure may enhance reactivity and contribute to innovative medicinal chemistry efforts. -
Drug Impurity
Clopidogrel impurity 1 is a known impurity of the antiplatelet agent Clopidogrel, primarily serving as a marker for quality control in pharmaceutical formulations. This compound is critical for analytical studies, enabling researchers to assess the purity and stability of Clopidogrel formulations. Its detection is essential for ensuring compliance with regulatory standards in drug development and safety evaluations. -
Drug Intermediate
Benzyl tetrahydro-1H-pyrrolo[3,4-c]isoxazole-5(3H)-carboxylate is a versatile drug intermediate utilized in the synthesis of diverse biologically active compounds. This compound plays a critical role in medicinal chemistry, facilitating the development of novel therapeutic agents. It is particularly relevant in the exploration of pharmacological applications and structural modifications in drug design. -
Drug Impurity
Naproxen impurity 1 is a known impurity of the nonsteroidal anti-inflammatory drug (NSAID) Naproxen. It is relevant in pharmacokinetic studies, quality control processes, and stability testing of pharmaceutical formulations. This compound is essential for understanding the safety and efficacy profiles of Naproxen and its related formulations. Researchers may utilize this impurity to investigate potential side effects and ensure regulatory compliance in drug development. -
Drug Impurity
Edoxaban impurity 1 is a byproduct associated with Edoxaban, an anticoagulant medication targeting factor Xa. This impurity is relevant for analytical chemistry and quality control studies, where it serves as a reference standard for the identification and quantification of impurities in drug formulations. Its presence in stability studies is critical for ensuring the purity and efficacy of Edoxaban in pharmaceutical applications. -
Bupivacaine Impurity
2,6-Dichlorocapronic acid xylidide is an impurity associated with Bupivacaine, a commonly used local anesthetic. This compound’s presence may impact the purity and efficacy of Bupivacaine formulations. It serves as an important reference for analytical studies and quality control in pharmaceutical research related to local anesthetics. -
Drug Impurity
Gabapentin acid impurity 1, an impurity of Gabapentin acid, is primarily utilized as a reference standard in analytical chemistry. Its characterization is crucial for ensuring the quality and consistency of gabapentin formulations. This compound serves an important role in research applications focused on the determination of drug purity and assessment of pharmacological profiles. -
Drug Impurity
Clevidipine butyrate impurity 1 is a known impurity of Clevidipine butyrate, which is a calcium channel blocker used in the management of hypertension. This compound serves as a reference standard for analytical tests and quality control assessments in pharmaceutical development. Researchers can utilize this impurity to ensure the purity and safety of drug formulations containing Clevidipine butyrate. -
Drug Impurity
rel-Bedaquiline is a known impurity of the anti-tuberculosis drug bedaquiline. It may exhibit biological activity relevant to the evaluation of drug safety and efficacy in tuberculosis research. This compound is essential for analytical studies focusing on drug purity and the comprehensive assessment of pharmaceutical formulations. -
Drug Intermediate
2-Thiazolemethanamine, α-(phenylmethyl)-, (R)- serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural properties facilitate the development of various biologically active molecules, making it integral for pharmaceutical research and development. This reagent is particularly useful in the creation of compounds with therapeutic potential targeting a range of diseases. -
Drug Impurity
Bazedoxifene impurity 2 is a byproduct of Bazedoxifene, which targets estrogen receptors. This compound is critical in assessing drug purity and stability, as well as understanding the safety and efficacy profiles of Bazedoxifene. It is relevant in pharmaceutical research focusing on selective estrogen receptor modulators (SERMs) and their associated properties. -
Drug Impurity
Ticagrelor impurity 8 is a chemical impurity associated with the antiplatelet agent Ticagrelor. This impurity is essential for assessing the purity and stability of Ticagrelor formulations in pharmaceutical research. It plays a crucial role in ensuring the safety and efficacy of drug products and is relevant in synthetic and analytical chemistry applications related to cardiovascular studies. -
Drug Impurity
Metoprolol impurity 3 hydrochloride is a chemical impurity associated with the synthesis of Metoprolol hydrochloride, a selective beta-1 adrenergic blocker. This impurity is relevant for pharmaceutical quality control and analytical studies, aiding in the purification and characterization of active pharmaceutical ingredients. Its presence may impact the safety and efficacy profiles of drug formulations, making it essential for compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Vonoprazan impurity 4 is a structural derivative of Vonoprazan, primarily classified as a drug impurity. It is utilized in the analytical study and quality control of pharmaceutical formulations containing Vonoprazan. This compound aids in understanding the stability and purity of the drug, ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Intermediate
Ethyl-2-amino-4-phenyl thiophene-3-carboxylate functions as a valuable synthetic intermediate in pharmaceutical synthesis. This compound serves as a building block for the development of a variety of bioactive molecules. Its versatility makes it suitable for research involving drug discovery and the synthesis of novel therapeutic agents. -
Drug Impurity
Pantoprazole impurity 43 is a substance related to Pantoprazole, primarily identified as a drug impurity. This compound is utilized in the research of pharmaceutical formulations and quality control assessments, aiding in the identification and characterization of impurities in drug development processes. Its analysis is crucial for ensuring the safety and efficacy of Pantoprazole-based therapies. -
Oseltamivir Impurity
Ethyl 4-acetamido-3-hydroxybenzoate is a known impurity of Oseltamivir, an antiviral medication effective against influenza viruses. This compound is utilized in the assessment of Oseltamivir purity and stability during pharmaceutical development and quality control processes. Its precise characterization aids researchers in understanding the implications of impurities on drug efficacy and safety profiles. -
Drug Impurity
Brexpiprazole impurity 1 is a chemical impurity related to the atypical antipsychotic Brexpiprazole, which primarily targets serotonin and dopamine receptors. This impurity can be utilized in the assessment of drug quality and to investigate the stability and degradation pathways of Brexpiprazole. Its presence may influence the pharmacological profile and safety evaluations in related research applications. -
Drug Impurity
Enzalutamide impurity 4 is a recognized impurity associated with Enzalutamide, a potent androgen receptor inhibitor. This compound is essential for analytical research, particularly in assessing the purity and stability of Enzalutamide formulations. It serves as a valuable tool in drug development and quality control processes, facilitating the identification and quantification of impurities in pharmaceutical applications.
